Streetbeat News

Price Targets

FBIN

Barclays analyst Matthew Bouley maintains an Overweight rating on Fortune Brands (NYSE:FBIN) but has lowered the price target from $74 to $66.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:31 am

FTV

Barclays analyst Julian Mitchell maintains an Overweight rating on Fortive (NYSE:FTV) but lowers the price target from $83 to $76.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:28 am

DOW

Barclays analyst Michael Leithead has maintained an Equal-Weight rating on Dow (NYSE:DOW) and lowered the price target from $56 to $52.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:25 am

DHR

Barclays analyst Luke Sergott maintains an Overweight rating on Danaher (NYSE:DHR) but lowers the price target from $290 to $215.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:24 am

CCK

Barclays analyst Michael Leithead maintains an Overweight rating on Crown Holdings (NYSE:CCK) but lowers the price target from $110 to $100.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:22 am

MKTX

Rosenblatt analyst Andrew Bond maintains a 'Sell' rating on MarketAxess Holdings (NASDAQ:MKTX) and has lowered the price target from $206 to $203.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:17 am

CME

Rosenblatt analyst Andrew Bond maintains a 'Sell' rating on CME Group (NASDAQ:CME) and raises the price target from $173 to $180.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:11 am

META

Rosenblatt analyst Barton Crockett maintains a 'Buy' rating on Meta Platforms (NASDAQ:META) and has raised the price target from $372 to $411.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:09 am

MSFT

Rosenblatt analyst Blair Abernethy maintains a 'Buy' rating on Microsoft (NASDAQ:MSFT) and has raised the price target from $370 to $375.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 11:03 am

CME

Barclays analyst Jeremy Campbell has maintained an Overweight rating on CME Group (NASDAQ:CME) but lowered the price target from $247 to $244.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 10:59 am